Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$407K Buy
26,463
+65
+0.2% +$1.08K ﹤0.01% 3668
2025
Q4
$476K Buy
26,398
+280
+1% +$4.82K ﹤0.01% 3595
2025
Q3
$421K Buy
26,118
+252
+1% +$3.69K ﹤0.01% 3663
2025
Q2
$282K Buy
25,866
+369
+1% +$4.13K ﹤0.01% 3908
2025
Q1
$318K Sell
25,497
-74,503
-75% -$1.23M ﹤0.01% 3916
2024
Q4
$1.98M Buy
+100,000
New +$1.11M ﹤0.01% 2830
2022
Q4
Sell
-48
Closed 5879
2022
Q3
$0 Buy
48
+3
+7% +$18 ﹤0.01% 6132
2022
Q2
$0 Sell
45
-157
-78% -$1.08K ﹤0.01% 6484
2022
Q1
$2K Buy
202
+166
+461% +$1.41K ﹤0.01% 6075
2021
Q4
$0 Buy
+36
New +$418 ﹤0.01% 5998
2021
Q3
Sell
-500
Closed -$7K 6087
2021
Q2
$7K Hold
500
﹤0.01% 5768
2021
Q1
$8K Sell
500
-30,400
-98% -$574K ﹤0.01% 5761
2020
Q4
$524K Buy
30,900
+29,950
+3,153% +$737K ﹤0.01% 4163
2020
Q3
$35K Buy
950
+500
+111% +$15.7K ﹤0.01% 5823
2020
Q2
$10K Buy
+450
New +$9.63K ﹤0.01% 7049
2016
Q4
Sell
-16,500
Closed -$142K 7264
2016
Q3
$142K Hold
16,500
﹤0.01% 4941
2016
Q2
$131K Buy
16,500
+16,497
+549,900% +$237K ﹤0.01% 4855
2016
Q1
$0 Sell
3
-22
-88% -$302 ﹤0.01% 7630
2015
Q4
$0 Buy
+25
New +$306 ﹤0.01% 7737

Other funds holding MESO

Citigroup's MESO Position: Q1 2026 in Review

Citigroup increased its Mesoblast (MESO) stake by 0.25% in Q1 2026, buying an estimated $1.08K and bringing the position to 26,463 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #3668.

Citigroup first reported a position in MESO in Q4 2015 and has held it in 19 quarters since. The position peaked at $1.98M in Q4 2024. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Citigroup held 26,463 shares of Mesoblast worth $407K as of Q1 2026.
  • Citigroup bought 65 Mesoblast shares in Q1 2026, an estimated $1.08K.
  • Mesoblast made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3668 holding.
  • Citigroup first reported a position in Mesoblast in Q4 2015 and has held it in 19 quarters since.
  • Citigroup's Mesoblast position peaked at $1.98M in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.